Search Results

There are 5100 results for: content related to: Rofecoxib versus Hydrocodone/Acetaminophen for Postoperative Analgesia in Functional Endoscopic Sinus Surgery

  1. Rofecoxib for osteoarthritis

    Intervention Review

    The Cochrane Library

    Sarah E Garner, Dogan Fidan, Ruth R Frankish and Lara Maxwell

    Published Online : 24 JAN 2005, DOI: 10.1002/14651858.CD005115

  2. Rofecoxib for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Sarah E Garner, Dogan Fidan, Ruth R Frankish, Maria Judd, Tanveer Towheed, Peter Tugwell and George A Wells

    Published Online : 24 JAN 2005, DOI: 10.1002/14651858.CD003685.pub2

  3. Single dose oral rofecoxib for acute postoperative pain in adults

    Intervention Review

    The Cochrane Library

    Simon Bulley, Sheena Derry, R Andrew Moore and Henry J McQuay

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD004604.pub3

  4. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

    Clinical Pharmacology & Therapeutics

    Volume 65, Issue 3, March 1999, Pages: 336–347, Elliot W. Ehrich, Aimee Dallob, Inge De Lepeleire, Anne Van Hecken, Denis Riendeau, Weiying Yuan, Arturo Porras, Johanna Wittreich, James R. Seibold, Paul De Schepper, Donald R. Mehlisch and Barry J. Gertz

    Version of Record online : 10 MAR 1999, DOI: 10.1016/S0009-9236(99)70113-X

  5. You have free access to this content
    Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 62, Issue 3, September 2006, Pages: 345–357, Janne T. Backman, Marjo J. Karjalainen, Mikko Neuvonen, Jouko Laitila and Pertti J. Neuvonen

    Version of Record online : 21 APR 2006, DOI: 10.1111/j.1365-2125.2006.02653.x

  6. You have free access to this content
    Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells

    Journal of Digestive Diseases

    Volume 11, Issue 1, February 2010, Pages: 34–42, Feng Shang ZHU, Xi Mei CHEN, Zhi Gang HUANG, Zhi Rong WANG, Dong Wei ZHANG and Xia ZHANG

    Version of Record online : 3 FEB 2010, DOI: 10.1111/j.1751-2980.2009.00411.x

  7. You have free access to this content
    The gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

    Alimentary Pharmacology & Therapeutics

    Volume 15, Issue 1, January 2001, Pages: 1–9, C. J. Hawkey, L. Jackson, S. E. Harper, T. J. Simon, E. Mortensen and C. R. Lines

    Version of Record online : 7 JUL 2008, DOI: 10.1046/j.1365-2036.2001.00894.x

  8. Combining paracetamol with a selective cyclooxygenase-2 inhibitor for acute pain relief after third molar surgery: a randomized, double-blind, placebo-controlled study

    European Journal of Oral Sciences

    Volume 114, Issue 4, August 2006, Pages: 293–301, Birgitta Haglund and Inger Von Bültzingslöwen

    Version of Record online : 25 JUL 2006, DOI: 10.1111/j.1600-0722.2006.00365.x

  9. Rofecoxib in the Acute Treatment of Migraine: A Randomized Controlled Clinical Trial

    Headache: The Journal of Head and Face Pain

    Volume 46, Issue 2, February 2006, Pages: 264–275, Joel Saper, Carl Dahlof, Yuen So, Peer Tfelt-Hansen, William Malbecq, Thomas Loeys, Eleathea Barraclough, Meghan Klipfel, Christopher Lines, Hester Visser, Scott Reines, Eric Yuen and on behalf of the Rofecoxib Protocol 162 Study Group

    Version of Record online : 21 FEB 2006, DOI: 10.1111/j.1526-4610.2006.00334.x

  10. You have free access to this content
    Enhanced inhibitive effects of combination of rofecoxib and octreotide on the growth of human gastric cancer

    International Journal of Cancer

    Volume 112, Issue 3, 10 November 2004, Pages: 470–474, Chengwei Tang, Chunlun Liu, Xuchun Zhou and Chunhui Wang

    Version of Record online : 23 JUN 2004, DOI: 10.1002/ijc.20256

  11. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain

    Acta Anaesthesiologica Scandinavica

    Volume 48, Issue 5, May 2004, Pages: 525–546, J. Rømsing and S. Møiniche

    Version of Record online : 21 APR 2004, DOI: 10.1111/j.0001-5172.2004.00379.x

  12. You have full text access to this Open Access content
    Selective inhibition of prostacyclin synthase activity by rofecoxib

    Journal of Cellular and Molecular Medicine

    Volume 11, Issue 2, March/April 2007, Pages: 327–338, Cristiana Griffoni, Enzo Spisni, Antonio Strillacci, Mattia Toni, Markus Michael Bachschmid and Vittorio Tomasi

    Version of Record online : 1 MAY 2007, DOI: 10.1111/j.1582-4934.2007.00021.x

  13. An Evaluation of the Dose-Dependent Inhibition of CYP1A2 by Rofecoxib Using Theophylline as a CYP1A2 Probe

    The Journal of Clinical Pharmacology

    Volume 43, Issue 10, October 2003, Pages: 1082–1090, Dr. Kenneth Bachmann, Dr. Donald White, Dr. Luis Jauregui, Dr. Jules I. Schwartz, Dr. Nancy G. B. Agrawal, Mr. Ralph Mazenko, Mr. Patrick J. Larson and Dr. Arturo G. Porras

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003257454

  14. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans

    Clinical Pharmacology & Therapeutics

    Volume 65, Issue 6, June 1999, Pages: 653–660, Jules I. Schwartz, Chi-Chung Chan, Saurabh Mukhopadhyay, Kathleen J. McBride, Terry M. Jones, Sherilyn Adcock, Carl Moritz, Jerris Hedges, Kenneth Grasing, David Dobratz, Robert A. Cohen, Michael H. Davidson, Kenneth A. Bachmann and Barry J. Gertz

    Version of Record online : 17 JUN 1999, DOI: 10.1016/S0009-9236(99)90087-5

  15. You have full text access to this Open Access content
    IL-10 production in non–small cell lung carcinoma patients is regulated by ERK, P38 and COX-2

    Journal of Cellular and Molecular Medicine

    Volume 16, Issue 3, March 2012, Pages: 531–544, Swati Patel, Shamal Vetale, Pradeep Teli, Rajesh Mistry and Shubhada Chiplunkar

    Version of Record online : 28 FEB 2012, DOI: 10.1111/j.1582-4934.2011.01329.x

  16. Effect of Rofecoxib on Prednisolone and Prednisone Pharmacokinetics in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 43, Issue 2, February 2003, Pages: 187–192, Jules I. Schwartz, Saurabh Mukhopadhyay, Arturo G. Porras, Kala-Jyoti Viswanathan-Aiyer, Sherilyn Adcock, David L. Ebel and Barry J. Gertz

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270002239828

  17. You have free access to this content
    Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats

    British Journal of Pharmacology

    Volume 153, Issue 5, March 2008, Pages: 1072–1084, D R H Huntjens, A Strougo, A Chain, A Metcalf, S Summerfield, D J M Spalding, M Danhof and O Della Pasqua

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707643

  18. You have free access to this content
    Cyclo-oxygenase-2 inhibition increases blood pressure in rats

    British Journal of Pharmacology

    Volume 136, Issue 8, August 2002, Pages: 1117–1126, Klaus Höcherl, Dierk Endemann, Martin C Kammerl, Horst F Grobecker and Armin Kurtz

    Version of Record online : 2 FEB 2009, DOI: 10.1038/sj.bjp.0704821

  19. You have free access to this content
    Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: What is the potential impact of the withdrawal of rofecoxib?

    Arthritis Care & Research

    Volume 55, Issue 1, 15 February 2006, Pages: 27–34, Elham Rahme, Elke Hunsche, Youssef Toubouti and Isabelle Chabot

    Version of Record online : 6 FEB 2006, DOI: 10.1002/art.21696

  20. You have free access to this content
    Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisition

    Epilepsia

    Volume 52, Issue 2, February 2011, Pages: 273–283, Robert J. Claycomb, Sandra J. Hewett and James A. Hewett

    Version of Record online : 10 JAN 2011, DOI: 10.1111/j.1528-1167.2010.02889.x